Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 103 entries
Sorted by: Best Match Show Resources per page
Reduction in heart failure hospitalization rate during coronavirus disease 19 pandemic outbreak.

ESC heart failure

Severino P, D'Amato A, Saglietto A, D'Ascenzo F, Marini C, Schiavone M, Ghionzoli N, Pirrotta F, Troiano F, Cannillo M, Mennuni M, Rognoni A, Rametta F, Galluzzo A, Agnes G, Infusino F, Pucci M, Lavalle C, Cacciotti L, Mather PJ, Grosso Marra W, Ugo F, Forleo G, Viecca M, Morici N, Patti G, De Ferrari GM, Palazzuoli A, Mancone M, Fedele F.
PMID: 33094929
ESC Heart Fail. 2020 Oct 23; doi: 10.1002/ehf2.13043. Epub 2020 Oct 23.

AIMS: The recent coronavirus disease 19 (COVID-19) pandemic outbreak forced the adoption of restraint measures, which modified the hospital admission patterns for several diseases. The aim of the study is to investigate the rate of hospital admissions for heart...

Cite
Severino P, D'Amato A, Saglietto A, et al. Reduction in heart failure hospitalization rate during coronavirus disease 19 pandemic outbreak. ESC Heart Fail. 2020;doi: 10.1002/ehf2.13043.
Severino, P., D'Amato, A., Saglietto, A., D'Ascenzo, F., Marini, C., Schiavone, M., Ghionzoli, N., Pirrotta, F., Troiano, F., Cannillo, M., Mennuni, M., Rognoni, A., Rametta, F., Galluzzo, A., Agnes, G., Infusino, F., Pucci, M., Lavalle, C., Cacciotti, L., Mather, P. J., Grosso Marra, W., Ugo, F., Forleo, G., Viecca, M., Morici, N., Patti, G., De Ferrari, G. M., Palazzuoli, A., Mancone, M., & Fedele, F. (2020). Reduction in heart failure hospitalization rate during coronavirus disease 19 pandemic outbreak. ESC heart failure, . https://doi.org/10.1002/ehf2.13043
Severino, Paolo, et al. "Reduction in heart failure hospitalization rate during coronavirus disease 19 pandemic outbreak." ESC heart failure vol. (2020). doi: https://doi.org/10.1002/ehf2.13043
Severino P, D'Amato A, Saglietto A, D'Ascenzo F, Marini C, Schiavone M, Ghionzoli N, Pirrotta F, Troiano F, Cannillo M, Mennuni M, Rognoni A, Rametta F, Galluzzo A, Agnes G, Infusino F, Pucci M, Lavalle C, Cacciotti L, Mather PJ, Grosso Marra W, Ugo F, Forleo G, Viecca M, Morici N, Patti G, De Ferrari GM, Palazzuoli A, Mancone M, Fedele F. Reduction in heart failure hospitalization rate during coronavirus disease 19 pandemic outbreak. ESC Heart Fail. 2020 Oct 23; doi: 10.1002/ehf2.13043. Epub 2020 Oct 23. PMID: 33094929; PMCID: PMC7754919.
Copy Download .nbib Format: NLM
Impact of Cirrhosis on 90-Day Outcomes After Percutaneous Coronary Intervention.

The American journal of cardiology

Ponzetto A, De Ferrari GM.
PMID: 32291088
Am J Cardiol. 2020 Jun 01;125(11):1754. doi: 10.1016/j.amjcard.2020.03.008. Epub 2020 Mar 19.

No abstract available.

Cite
Ponzetto A, De Ferrari GM. Impact of Cirrhosis on 90-Day Outcomes After Percutaneous Coronary Intervention. Am J Cardiol. 2020;125(11):1754doi: 10.1016/j.amjcard.2020.03.008.
Ponzetto, A., & De Ferrari, G. M. (2020). Impact of Cirrhosis on 90-Day Outcomes After Percutaneous Coronary Intervention. The American journal of cardiology, 125(11), 1754. https://doi.org/10.1016/j.amjcard.2020.03.008
Ponzetto, Antonio, and De Ferrari, Gaetano Maria. "Impact of Cirrhosis on 90-Day Outcomes After Percutaneous Coronary Intervention." The American journal of cardiology vol. 125,11 (2020): 1754. doi: https://doi.org/10.1016/j.amjcard.2020.03.008
Ponzetto A, De Ferrari GM. Impact of Cirrhosis on 90-Day Outcomes After Percutaneous Coronary Intervention. Am J Cardiol. 2020 Jun 01;125(11):1754. doi: 10.1016/j.amjcard.2020.03.008. Epub 2020 Mar 19. PMID: 32291088.
Copy Download .nbib Format: NLM
Usefulness of oral anticoagulation in patients with coronary aneurysms: Insights from the CAAR registry.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

D'Ascenzo F, Saglietto A, Ramakrishna H, Andreis A, Jiménez-Mazuecos JM, Nombela-Franco L, Cerrato E, Liebetrau C, Alfonso-Rodríguez E, Bagur R, Alkhouli M, De Ferrari GM, Núñez-Gil IJ.
PMID: 32902099
Catheter Cardiovasc Interv. 2021 Nov 01;98(5):864-871. doi: 10.1002/ccd.29243. Epub 2020 Sep 09.

OBJECTIVES: To assess the Usefulness of oral anticoagulation therapy (OAT) in patients with coronary artery aneurysm (CAA).BACKGROUND: Data on the most adequate antithrombotic CAA management is lacking.METHODS: Patients included in CAAR (Coronary Artery Aneurysm Registry, Clinical Trials.gov: NCT02563626) were...

Cite
D'Ascenzo F, Saglietto A, Ramakrishna H, et al. Usefulness of oral anticoagulation in patients with coronary aneurysms: Insights from the CAAR registry. Catheter Cardiovasc Interv. 2020;98(5):864-871doi: 10.1002/ccd.29243.
D'Ascenzo, F., Saglietto, A., Ramakrishna, H., Andreis, A., Jiménez-Mazuecos, J. M., Nombela-Franco, L., Cerrato, E., Liebetrau, C., Alfonso-Rodríguez, E., Bagur, R., Alkhouli, M., De Ferrari, G. M., Núñez-Gil, I. J. (2021). Usefulness of oral anticoagulation in patients with coronary aneurysms: Insights from the CAAR registry. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 98(5), 864-871. https://doi.org/10.1002/ccd.29243
D'Ascenzo, Fabrizio, et al. "Usefulness of oral anticoagulation in patients with coronary aneurysms: Insights from the CAAR registry." Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions vol. 98,5 (2021): 864-871. doi: https://doi.org/10.1002/ccd.29243
D'Ascenzo F, Saglietto A, Ramakrishna H, Andreis A, Jiménez-Mazuecos JM, Nombela-Franco L, Cerrato E, Liebetrau C, Alfonso-Rodríguez E, Bagur R, Alkhouli M, De Ferrari GM, Núñez-Gil IJ. Usefulness of oral anticoagulation in patients with coronary aneurysms: Insights from the CAAR registry. Catheter Cardiovasc Interv. 2021 Nov 01;98(5):864-871. doi: 10.1002/ccd.29243. Epub 2020 Sep 09. PMID: 32902099.
Copy Download .nbib Format: NLM
Future Perspectives and New "Frontiers" in Cardiac Rhythmology.

Frontiers in cardiovascular medicine

Anselmino M, De Ferrari GM.
PMID: 33005631
Front Cardiovasc Med. 2020 Aug 26;7:126. doi: 10.3389/fcvm.2020.00126. eCollection 2020.

In the last three decades the Cardiac Rhythmology field has experienced tremendous change and evolution. Our understanding of the underlying mechanism of arrhythmic diseases has dramatically improved, starting from the genetic and molecular mechanisms. Innovative pharmacological and non-pharmacological treatment...

Cite
Anselmino M, De Ferrari GM. Future Perspectives and New "Frontiers" in Cardiac Rhythmology. Front Cardiovasc Med. 2020;7:126doi: 10.3389/fcvm.2020.00126.
Anselmino, M., & De Ferrari, G. M. (2020). Future Perspectives and New "Frontiers" in Cardiac Rhythmology. Frontiers in cardiovascular medicine, 7126. https://doi.org/10.3389/fcvm.2020.00126
Anselmino, Matteo, and De Ferrari, Gaetano Maria. "Future Perspectives and New "Frontiers" in Cardiac Rhythmology." Frontiers in cardiovascular medicine vol. 7 (2020): 126. doi: https://doi.org/10.3389/fcvm.2020.00126
Anselmino M, De Ferrari GM. Future Perspectives and New "Frontiers" in Cardiac Rhythmology. Front Cardiovasc Med. 2020 Aug 26;7:126. doi: 10.3389/fcvm.2020.00126. eCollection 2020. PMID: 33005631; PMCID: PMC7479197.
Copy Download .nbib Format: NLM
Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction: A Prespecified Secondary Analysis From the FOURIER Trial.

JAMA cardiology

Gencer B, Mach F, Murphy SA, De Ferrari GM, Huber K, Lewis BS, Ferreira J, Kurtz CE, Wang H, Honarpour N, Keech AC, Sever PS, Pedersen TR, Sabatine MS, Giugliano RP.
PMID: 32432684
JAMA Cardiol. 2020 Aug 01;5(8):952-957. doi: 10.1001/jamacardio.2020.0882.

IMPORTANCE: The 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol identified patients with recent (past 12 months) myocardial infarction (MI) as very high risk, in whom a PCSK9 inhibitor is reasonable to...

Cite
Gencer B, Mach F, Murphy SA, et al. Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction: A Prespecified Secondary Analysis From the FOURIER Trial. JAMA Cardiol. 2020;5(8):952-957doi: 10.1001/jamacardio.2020.0882.
Gencer, B., Mach, F., Murphy, S. A., De Ferrari, G. M., Huber, K., Lewis, B. S., Ferreira, J., Kurtz, C. E., Wang, H., Honarpour, N., Keech, A. C., Sever, P. S., Pedersen, T. R., Sabatine, M. S., & Giugliano, R. P. (2020). Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction: A Prespecified Secondary Analysis From the FOURIER Trial. JAMA cardiology, 5(8), 952-957. https://doi.org/10.1001/jamacardio.2020.0882
Gencer, Baris, et al. "Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction: A Prespecified Secondary Analysis From the FOURIER Trial." JAMA cardiology vol. 5,8 (2020): 952-957. doi: https://doi.org/10.1001/jamacardio.2020.0882
Gencer B, Mach F, Murphy SA, De Ferrari GM, Huber K, Lewis BS, Ferreira J, Kurtz CE, Wang H, Honarpour N, Keech AC, Sever PS, Pedersen TR, Sabatine MS, Giugliano RP. Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction: A Prespecified Secondary Analysis From the FOURIER Trial. JAMA Cardiol. 2020 Aug 01;5(8):952-957. doi: 10.1001/jamacardio.2020.0882. PMID: 32432684; PMCID: PMC7240652.
Copy Download .nbib Format: NLM
Prognostic implications of impaired longitudinal left ventricular systolic function assessed by tissue Doppler imaging prior to transcatheter aortic valve implantation for severe aortic stenosis.

The international journal of cardiovascular imaging

Gallone G, Bruno F, Trenkwalder T, D'Ascenzo F, Islas F, Leone PP, Nicol P, Pellegrini C, Incaminato E, Jimenez-Quevedo P, Alvarez-Covarrubias HA, Bragato R, Andreis A, Salizzoni S, Rinaldi M, Kastrati A, Conrotto F, Joner M, Stefanini G, Nombela-Franco L, Xhepa E, Escaned J, De Ferrari GM.
PMID: 35006473
Int J Cardiovasc Imaging. 2022 Jan 10; doi: 10.1007/s10554-021-02519-2. Epub 2022 Jan 10.

Change in longitudinal left ventricular (LV) systolic function serves as an early marker of the deleterious effect of aortic stenosis (AS) and other cardiac comorbidities on cardiac function. We explored the prognostic value of tissue Doppler imaging (TDI)-derived longitudinal...

Cite
Gallone G, Bruno F, Trenkwalder T, et al. Prognostic implications of impaired longitudinal left ventricular systolic function assessed by tissue Doppler imaging prior to transcatheter aortic valve implantation for severe aortic stenosis. Int J Cardiovasc Imaging. 2022;doi: 10.1007/s10554-021-02519-2.
Gallone, G., Bruno, F., Trenkwalder, T., D'Ascenzo, F., Islas, F., Leone, P. P., Nicol, P., Pellegrini, C., Incaminato, E., Jimenez-Quevedo, P., Alvarez-Covarrubias, H. A., Bragato, R., Andreis, A., Salizzoni, S., Rinaldi, M., Kastrati, A., Conrotto, F., Joner, M., Stefanini, G., Nombela-Franco, L., Xhepa, E., Escaned, J., & De Ferrari, G. M. (2022). Prognostic implications of impaired longitudinal left ventricular systolic function assessed by tissue Doppler imaging prior to transcatheter aortic valve implantation for severe aortic stenosis. The international journal of cardiovascular imaging, . https://doi.org/10.1007/s10554-021-02519-2
Gallone, Guglielmo, et al. "Prognostic implications of impaired longitudinal left ventricular systolic function assessed by tissue Doppler imaging prior to transcatheter aortic valve implantation for severe aortic stenosis." The international journal of cardiovascular imaging vol. (2022). doi: https://doi.org/10.1007/s10554-021-02519-2
Gallone G, Bruno F, Trenkwalder T, D'Ascenzo F, Islas F, Leone PP, Nicol P, Pellegrini C, Incaminato E, Jimenez-Quevedo P, Alvarez-Covarrubias HA, Bragato R, Andreis A, Salizzoni S, Rinaldi M, Kastrati A, Conrotto F, Joner M, Stefanini G, Nombela-Franco L, Xhepa E, Escaned J, De Ferrari GM. Prognostic implications of impaired longitudinal left ventricular systolic function assessed by tissue Doppler imaging prior to transcatheter aortic valve implantation for severe aortic stenosis. Int J Cardiovasc Imaging. 2022 Jan 10; doi: 10.1007/s10554-021-02519-2. Epub 2022 Jan 10. PMID: 35006473.
Copy Download .nbib Format: NLM
The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials.

The Canadian journal of cardiology

Gallone G, Baldetti L, Angelini F, Saglietto A, Bellettini M, Beneduce A, Ranotti V, Chiarito M, Leone PP, Pagnesi M, De Filippo O, Landra F, Bruno F, Marengo G, Collino M, Ferrante G, Stefanini GG, Colombo A, Al-Lamee R, Francis DP, Jolicoeur ME, Henry TD, Giannini F, D'Ascenzo F, De Ferrari GM.
PMID: 33974991
Can J Cardiol. 2021 May 08; doi: 10.1016/j.cjca.2021.04.022. Epub 2021 May 08.

BACKGROUND: The placebo effect is a well described phenomenon in blinded studies evaluating antianginal therapeutics, although its effect on clinical research metrics remains unknown. We conducted a systematic review and meta-analysis to quantify the effect of placebo on end...

Cite
Gallone G, Baldetti L, Angelini F, et al. The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials. Can J Cardiol. 2021;doi: 10.1016/j.cjca.2021.04.022.
Gallone, G., Baldetti, L., Angelini, F., Saglietto, A., Bellettini, M., Beneduce, A., Ranotti, V., Chiarito, M., Leone, P. P., Pagnesi, M., De Filippo, O., Landra, F., Bruno, F., Marengo, G., Collino, M., Ferrante, G., Stefanini, G. G., Colombo, A., Al-Lamee, R., Francis, D. P., Jolicoeur, M. E., Henry, T. D., Giannini, F., D'Ascenzo, F., & De Ferrari, G. M. (2021). The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials. The Canadian journal of cardiology, . https://doi.org/10.1016/j.cjca.2021.04.022
Gallone, Guglielmo, et al. "The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials." The Canadian journal of cardiology vol. (2021). doi: https://doi.org/10.1016/j.cjca.2021.04.022
Gallone G, Baldetti L, Angelini F, Saglietto A, Bellettini M, Beneduce A, Ranotti V, Chiarito M, Leone PP, Pagnesi M, De Filippo O, Landra F, Bruno F, Marengo G, Collino M, Ferrante G, Stefanini GG, Colombo A, Al-Lamee R, Francis DP, Jolicoeur ME, Henry TD, Giannini F, D'Ascenzo F, De Ferrari GM. The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials. Can J Cardiol. 2021 May 08; doi: 10.1016/j.cjca.2021.04.022. Epub 2021 May 08. PMID: 33974991.
Copy Download .nbib Format: NLM
A review of machine learning for cardiology.

Minerva cardiology and angiology

Arfat Y, Mittone G, Esposito R, Cantalupo B, DE Ferrari GM, Aldinucci M.
PMID: 34338485
Minerva Cardiol Angiol. 2021 Aug 02; doi: 10.23736/S2724-5683.21.05709-4. Epub 2021 Aug 02.

This paper reviews recent cardiology literature and reports how Artificial Intelligence Tools (specifically, Machine Learning techniques) are being used by physicians in the field. Each technique is introduced with enough details to allow the understanding of how it works...

Cite
Arfat Y, Mittone G, Esposito R, et al. A review of machine learning for cardiology. Minerva Cardiol Angiol. 2021;doi: 10.23736/S2724-5683.21.05709-4.
Arfat, Y., Mittone, G., Esposito, R., Cantalupo, B., DE Ferrari, G. M., & Aldinucci, M. (2021). A review of machine learning for cardiology. Minerva cardiology and angiology, . https://doi.org/10.23736/S2724-5683.21.05709-4
Arfat, Yasir, et al. "A review of machine learning for cardiology." Minerva cardiology and angiology vol. (2021). doi: https://doi.org/10.23736/S2724-5683.21.05709-4
Arfat Y, Mittone G, Esposito R, Cantalupo B, DE Ferrari GM, Aldinucci M. A review of machine learning for cardiology. Minerva Cardiol Angiol. 2021 Aug 02; doi: 10.23736/S2724-5683.21.05709-4. Epub 2021 Aug 02. PMID: 34338485.
Copy Download .nbib Format: NLM
Outcomes during the first year following spontaneous coronary artery dissection: A systematic timeframe pooled analysis.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Bocchino PP, Franchin L, Angelini F, D'Ascenzo F, De Ferrari GM, Alfonso F.
PMID: 34773431
Catheter Cardiovasc Interv. 2021 Nov 13; doi: 10.1002/ccd.30016. Epub 2021 Nov 13.

OBJECTIVES: We aimed to compare the incidence and timing of major adverse cardiovascular events (MACE) within the first year after spontaneous coronary artery dissection (SCAD) according to the management strategy: conservative versus invasive.BACKGROUND: Treatment of SCAD remains controversial.METHODS: A...

Cite
Bocchino PP, Franchin L, Angelini F, et al. Outcomes during the first year following spontaneous coronary artery dissection: A systematic timeframe pooled analysis. Catheter Cardiovasc Interv. 2021;doi: 10.1002/ccd.30016.
Bocchino, P. P., Franchin, L., Angelini, F., D'Ascenzo, F., De Ferrari, G. M., & Alfonso, F. (2021). Outcomes during the first year following spontaneous coronary artery dissection: A systematic timeframe pooled analysis. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, . https://doi.org/10.1002/ccd.30016
Bocchino, Pier Paolo, et al. "Outcomes during the first year following spontaneous coronary artery dissection: A systematic timeframe pooled analysis." Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions vol. (2021). doi: https://doi.org/10.1002/ccd.30016
Bocchino PP, Franchin L, Angelini F, D'Ascenzo F, De Ferrari GM, Alfonso F. Outcomes during the first year following spontaneous coronary artery dissection: A systematic timeframe pooled analysis. Catheter Cardiovasc Interv. 2021 Nov 13; doi: 10.1002/ccd.30016. Epub 2021 Nov 13. PMID: 34773431.
Copy Download .nbib Format: NLM
Corrigendum to "Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous Systems".

Mediators of inflammation

Dusi V, Ghidoni A, Ravera A, De Ferrari GM, Calvillo L.
PMID: 29540994
Mediators Inflamm. 2018 Jan 10;2018:4128049. doi: 10.1155/2018/4128049. eCollection 2018.

[This corrects the article DOI: 10.1155/2016/5902947.].

Cite
Dusi V, Ghidoni A, Ravera A, et al. Corrigendum to "Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous Systems". Mediators Inflamm. 2018;2018:4128049doi: 10.1155/2018/4128049.
Dusi, V., Ghidoni, A., Ravera, A., De Ferrari, G. M., & Calvillo, L. (2018). Corrigendum to "Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous Systems". Mediators of inflammation, 20184128049. https://doi.org/10.1155/2018/4128049
Dusi, Veronica, et al. "Corrigendum to "Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous Systems"." Mediators of inflammation vol. 2018 (2018): 4128049. doi: https://doi.org/10.1155/2018/4128049
Dusi V, Ghidoni A, Ravera A, De Ferrari GM, Calvillo L. Corrigendum to "Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous Systems". Mediators Inflamm. 2018 Jan 10;2018:4128049. doi: 10.1155/2018/4128049. eCollection 2018. PMID: 29540994; PMCID: PMC5818965.
Copy Download .nbib Format: NLM
Biomaterial-Based "Structured Opals" with Programmable Combination of Diffractive Optical Elements and Photonic Bandgap Effects.

Advanced materials (Deerfield Beach, Fla.)

Wang Y, Li W, Li M, Zhao S, De Ferrari F, Liscidini M, Omenetto FG.
PMID: 30520166
Adv Mater. 2019 Feb;31(5):e1805312. doi: 10.1002/adma.201805312. Epub 2018 Dec 06.

Naturally occurring iridescent systems produce brilliant color displays through multiscale, hierarchical assembly of structures that combine reflective, diffractive, diffusive, or absorbing domains. The fabrication of biopolymer-based, hierarchical 3D photonic crystals through the use of a topographical templating strategy that...

Cite
Wang Y, Li W, Li M, et al. Biomaterial-Based "Structured Opals" with Programmable Combination of Diffractive Optical Elements and Photonic Bandgap Effects. Adv Mater. 2018;31(5):e1805312doi: 10.1002/adma.201805312.
Wang, Y., Li, W., Li, M., Zhao, S., De Ferrari, F., Liscidini, M., & Omenetto, F. G. (2019). Biomaterial-Based "Structured Opals" with Programmable Combination of Diffractive Optical Elements and Photonic Bandgap Effects. Advanced materials (Deerfield Beach, Fla.), 31(5), e1805312. https://doi.org/10.1002/adma.201805312
Wang, Yu, et al. "Biomaterial-Based "Structured Opals" with Programmable Combination of Diffractive Optical Elements and Photonic Bandgap Effects." Advanced materials (Deerfield Beach, Fla.) vol. 31,5 (2019): e1805312. doi: https://doi.org/10.1002/adma.201805312
Wang Y, Li W, Li M, Zhao S, De Ferrari F, Liscidini M, Omenetto FG. Biomaterial-Based "Structured Opals" with Programmable Combination of Diffractive Optical Elements and Photonic Bandgap Effects. Adv Mater. 2019 Feb;31(5):e1805312. doi: 10.1002/adma.201805312. Epub 2018 Dec 06. PMID: 30520166.
Copy Download .nbib Format: NLM
Cardiac Sympathetic Denervation in Channelopathies.

Frontiers in cardiovascular medicine

Dusi V, De Ferrari GM, Pugliese L, Schwartz PJ.
PMID: 30972341
Front Cardiovasc Med. 2019 Mar 26;6:27. doi: 10.3389/fcvm.2019.00027. eCollection 2019.

Left cardiac sympathetic denervation (LCSD) is a surgical antiadrenergic intervention with a strong antiarrhythmic effect, supported by preclinical as well as clinical data. The mechanism of action of LCSD in structurally normal hearts with increased arrhythmic susceptibility (such as...

Cite
Dusi V, De Ferrari GM, Pugliese L, et al. Cardiac Sympathetic Denervation in Channelopathies. Front Cardiovasc Med. 2019;6:27doi: 10.3389/fcvm.2019.00027.
Dusi, V., De Ferrari, G. M., Pugliese, L., & Schwartz, P. J. (2019). Cardiac Sympathetic Denervation in Channelopathies. Frontiers in cardiovascular medicine, 627. https://doi.org/10.3389/fcvm.2019.00027
Dusi, Veronica, et al. "Cardiac Sympathetic Denervation in Channelopathies." Frontiers in cardiovascular medicine vol. 6 (2019): 27. doi: https://doi.org/10.3389/fcvm.2019.00027
Dusi V, De Ferrari GM, Pugliese L, Schwartz PJ. Cardiac Sympathetic Denervation in Channelopathies. Front Cardiovasc Med. 2019 Mar 26;6:27. doi: 10.3389/fcvm.2019.00027. eCollection 2019. PMID: 30972341; PMCID: PMC6443634.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 103 entries